Pocket Program - CROI

CROI 2013 Session 180
c Wednesday, 2:30-4 pm; Hall B2
Session 177–Poster Abstracts
HIV and ART-related Complications and Treatment
in Children and Youth
+ 959
Children in the Era of cART
P Williams1 , M Abzug2 , Denise Jacobson* 1 , J Wang1 , R Van Dyke3 ,
R Hazra4 , K Patel1 , L DiMeglio5 , J Oleske6 , M Geffner7 , and IMPAACT
219C and Pediatric HIV/AIDS Cohort Study Teams
1 2 Harvard Sch of Publ Hlth, Boston, MA, US;; Univ of Colorado Sch of
Med, Denver, US;; 3Tulane Univ Sch of Med, New Orleans, LA, US;; 4Natl Inst of Child Hlth and Human Devt, NIH, Bethesda, MD, US;; 5Indiana Univ Sch of Med, Indianapolis, US;; 6New Jersey Med Sch, Newark, US;;
and 7 960 Incidence of Lipodystrophy Syndrome in a European Cohort
of HIV + Children and Adolescents
N Alam 1 , M Cortina-Borja 1 , T Goetghebuer 2 , M Marczynska 3 , A Vigano 4 ,
Claire Thorne* 1 , and European Paediatric HIV and Lipodystrophy
Study in EuroCoord
1 Univ Coll London, UK;; 2 Ctr Hosp Univ St Pierre, Brussels, Belgium;;
3 Med Univ of Warsaw, Poland;; and 4 Univ of Milan, Italy
+ 961
Pediatric and
Adolescent Patients: The Use of Speckle Tracking
M Alvarez Fuente1 , Talia Sainz* 1 , JT Ramos Amador2 , C Medrano3 ,
D Blazquez Gamero3 , MI de Jose4 , MJ Mellado5 , ML Navarro1 ,
P Rojo Conejo1 , and MA Munoz1 1 2 Hosp Gregorio Maranon, Madrid, Spain;; Hosp de Getafe, Madrid,
Spain;; 3Hosp 12 de Octubre, Madrid, Spain;; 4Hosp La Paz, Madrid,
Spain;; and 5Hosp Carlos III, Madrid, Spain
962 Hypertension in HIV + Children and Adolescents
Sam Chatterton-Kirchmeier* 1 , R Chakraborty 2 , A Camacho-Gonzalez 2 ,
and D Batisky 2
1 Emory Univ Sch of Med, Atlanta, GA, US and 2 Emory Univ, Atlanta,
GA, US
c Monday, 2:30-4 pm; Hall B2
Session 178–Poster Abstracts
Characteristics of Youth with HIV
957 Mortality among HIV + Children with Cancer in South
Africa: A Pilot Linkage Study
M Maskew1 , Julia Bohlius* 2 , C Stefan3 , A Davidson4 , N Maxwell1 ,
B Eley4 , H Prozesky5 , M Egger2 , and M-A Davies1 1 2 Univ of Cape Town, South Africa;; Inst of Social and Preventive Med,
Univ of Bern, Switzerland;; 3Univ of Stellenbosch, South Africa;; 4Red
5Tygerberg Hosp, Cape Town, South Africa
958
and Adolescents
P Martos1 , E Sanchez2 , A Noguera-Julian1 , J Lledo3 , A Mur3 ,
and Claudia Fortuny* 1
1 2 Hosp Sant Joan de Deu, Univ de Barcelona, Spain;; Univ Ramon Llull,
Barcelona, Spain;; and 3 966
or More after Perinatal HIV Infection: Agence Nationale de
S Blanche
Hosp del Mar, Univ Autonoma de Barcelona, Spain
1 , D Scott-Algara2 , J Le Chenadec3 , V Avettand-Fenoel1 ,
N Bouallag3 , C Rouzioux1 , J-P Viard4 , C Dollfus5 , J Warsawski3,6 ,
and Florence Buseyne* 2
1 2 Univ Paris Descartes, Hosp Necker, Paris, France;; Inst Pasteur, Paris,
France;; 3INSERM U1018, Le Kremlin-Bicetre, France;; 4Hosp de l’Hotel-
Dieu, Paris, France;; 5Hosp Trousseau, Paris, France;; and 6Univ Paris
Sud, Le Kremlin-Bicetre, France
+ 967
T Cell
Diversity Decades after Perinatal HIV-1 Infection
Christian Aguilera-Sandoval* 1 , O Yang1 , N Jojic2 , M Belzer3 ,
J Church3 , and P Krogstad1 1Geffen Sch of Med, Univ of California, Los Angeles Med Ctr, US;;
2 3 Microsoft Inc, US;; and
Southern California, Los Angeles, US
+ 963
Children from Latin
Development Initiative Study
Cristina Hofer* 1 , R Harris2 , R Oliveira1 , T de Abreu1 , F Kakehasi3 ,
JH Pilotto4 , N Pavia Ruz5 , M Krauss2 , R Hazra6 , and NISDI Pediatric
Study Group 2012
1Inst de Puericultura e Pediatria Martagao Gesteira, Rio de Janeiro,
Brazil;; 2Westat, Rockville, MD, US;; 3Uviv Federal de Minas Gerais, Belo
Horizonte, Brazil;; 4Hosp Geral Nova de Iguacu, Brazil;; 5Hosp Infantil de
Mexico Federico Gomez, Mexico City;; and 6Natl Inst of Child Hlth and
Human Devt, NIH, Bethesda, MD, US
964 Low Bone Mineral Density in Vertically HIV + Adolescents:
B Jimenez1 , Talia Sainz* 2 , L Diaz2 , ML Navarro2 , MI Gonzalez-Tome3 ,
MJ Mellado4 , MI de Jose5 , P Rojo3 , JT Ramos6 , MA Munoz-Fernandez2 ,
and Madrid Cohort of HIV-infected Children and Adolescents, Integrated
in CORISPE
1 2 Hosp Infanta Sofia, Madrid, Spain;; Hosp Gregorio Maranon, Madrid,
Spain;; 3Hosp 12 de Octubre, Madrid, Spain;; 4Hosp Carlos III, Madrid,
Spain;; 5Hosp La Paz, Madrid, Spain;; and 6Hosp de Getafe, Madrid, Spain
965 Vitamin D Children and Adults with HIV
A Steenhoff1,2,3,4 , J Schall2 , B Seme1 , M Marape5 , I Tsimako1 , M Tolle5 ,
M Nnyepi4 , L Mazhani4 , Richard Rutstein* 2,3 , and V Stallings2,3 1 2 Botswana-UPenn Partnership, Gaborone;;
Philadelphia, PA, US;; 3Perelman Sch of Med at the Univ of Pennsylvania,
Philadelphia, US;; 4Univ of Botswana, Gaborone;; and 5 Session 179–Poster Abstracts
(see Session 12 on Monday for corresponding Themed Discussion)
Tenofovir in Children
972
+
Once-daily HAART Regimen
L Aurpibul
Botswana-Baylor
1 , T Narkbunnam2 , Virat Sirisanthana* 1 , O Wittawatmongkol2 ,
W Phongsamart2 , T Sudjaritruk1 , T Cressey1,3,4 , and K Chokephaibulkit2 1 2 Chiang Mai Univ, Thailand;; Mahidol Univ, Bangkok, Thailand;;
3 4 Harvard Sch of Publ Hlth, Boston, MA, US;; and Inst de Recherche pour
le Devt, Marseille, France
973 Pharmacokinetics of Tenofovir in Thai Adolescents Using
Wasana Prasitsuebsai* 1 , S Kerr1,2 , N Thammajaruk1 , A Colbers3 ,
S Keadpudsa1 , T Chuanjaroen1 , M Gorowara1 , D Burger3 , A Sohn4 ,
and J Ananworanich1,5 1HIV-NAT Res Collaboration, Thai Red Cross AIDS Res Ctr, Bangkok;;
2 3 Kirby Inst, Univ of New South Wales, Sydney, Australia;; Radboud Univ
Nijmegen Med Ctr, The Netherlands;; 4TREAT Asia/amfAR-Fndn for AIDS
Res, Bangkok, Thailand;; and 5SEARCH, Thai Red Cross AIDS Res Ctr,
Bangkok
c Monday, 2:30-4 pm; Hall B2
Session 180–Poster Abstracts
ARV Pharmacokinetics in Children
Program 63
Poster Listings
968
Young Adults Infected Perinatally than in Older Patients
Nelly Briand* 1 , J-P Viard 2 , C Dollfus 3 , F Boufassa 1 , J Le Chenadec 1 ,
C Goujard 1,4 , R Seng 1 , S Blanche 5 , L Meyer 1,4,6 , J Warszawski 1,4,6 , and
ANRS EPF, COVERTE, PRIMO, SEROCO, COPANA Study Groups
1 INSERM U1018, CESP, Le Kremlin-Bicetre, France;; 2 AP-HP Hotel-
Dieu, Paris, France;; 3 AP-HP, Hosp Trousseau, Paris, France;; 4 AP-HP,
Hosp Bicetre, Paris, France;; 5 AP-HP Hosp Necker-Enfants Malades,
Univ Paris Descartes, Paris, France;; and 6 Univ Paris-Sud, Le Kremlin-
Bicetre, France
969
Allison Agwu* 1 , A Neptune 2 , R Rutstein 3 , T Korthuis 4 , K Gebo 1 ,
for HIV Res Network
1 Johns Hopkins Med Inst, Baltimore, MD, US;; 2 Howard Univ Coll of
Med, Washington, DC, US;; 3 Childrens Hosp of Philadelphia, PA, US;;
and 4 Oregon Hlth and Sci Univ, Portland, US
970
Behaviorally Acquired HIV
Sharon Nichols* 1 , J Bethel 2 , P Garvie 3 , D Patton 4 , S Thornton 2 ,
B Kapogiannis 5 , W Ren 2 , T Li 2 , H Major-Wilson 6 , S Woods 1 ,
and Adolescent Trials Network for HIV/AIDS Interventions
1 Univ of California, San Diego, La Jolla, US;; 2 Westat, Rockville, MD, US;;
3 Independent Consultant, Memphis, TN, US;; 4 Childrens Diagnostic and
Treatment Ctr, Inc, Fort Lauderdale, FL, US;; 5 NIH, Bethesda, MD, US;;
and 6 Univ of Miami, FL, US
974 Raltegravir Pharmacokinetics and Safety in Neonates
Diana Clarke* 1 , E Acosta 2 , M Rizk 3 , Y Bryson 4 , S Spector 5 ,
L Mofenson 6 , H Teppler 3 , C Welebob 3 , E Handelsman 7 , M Mirochnick 8 ,
and IMPAACT P1097 Study Team
1 Boston Med Ctr, MA US;; 2 Univ of Alabama at Birmingham, US;; 3 Merck
Res Labs, Clin Res, North Wales, PA, US;; 4 Univ of California, Los
Angeles, US;; 5 Univ of California, San Diego, US;; 6 Natl Inst of Child Hlth
and Human Devt, NIH, Bethesda, MD, US;; 7 NIAID, NIH, Bethesda, MD,
US;; and 8 Boston Univ, MA, US